Clinical Trial

Neuropathic Pain and Type II Diabetic Patients

Recruiting
View on ClinicalTrials.gov →
Summary
Diabetes Mellitus (DM) is a common metabolic disease characterized by hyperglycemia resulting from insufficiency, deficiency or absence of the insulin hormone. Chronic hyperglycemia, secondary metabolic and microvascular changes resulting in diabetic neuropathy are among the most common complications encountered in DM patients. Diabetic neuropathy is called peripheral, autonomic or spinal depending on the region of involvement. Peripheral involvement is more common than other region involvement and its prevalence in DM patients is observed to be 16-87%. Diabetic peripheral neuropathy (DPN) presents with numbness, tingling, paresthesia, muscle weakness and pain. These symptoms can start from the toes and progress to the leg and even the upper extremities. In diabetic peripheral neuropathy, pain is seen as burning, electric shock or sharp cold pain, increases at night and affects sleep quality. In these patients, daily living activities such as walking, climbing stairs, and sleeping are negatively affected by progressive DPN and pain, falls are observed, mood disorders are experienced, and the quality of life decreases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-28.
Trial Details
NCT Number NCT06798181
Lead Sponsor Bilecik Seyh Edebali Universitesi
Conditions Neuropathic Pain, Quality of Life, Diabetic Neuropathies
Enrollment 128 participants
Start Date 2024-12-15
Primary Completion 2025-06-15 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-30